À retenir
Among 36 251 UK Biobank participants followed for a median of 13.9 years, a rise in visit-to-visit systolic blood pressure variability was associated with a 23%-33% higher risk of cardiovascular disease, coronary heart disease, stroke, chronic kidney disease and death. It is an observational association, and the readings were taken from health records before enrolment, not from a standard protocol.
Study design
Article de recherche
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Blood pressure that swings widely between visits has been linked to poor outcomes, but earlier studies looked at variability in a single period. The authors tested how changes in systolic blood pressure variability (SBPV) over time, and different change patterns, relate to cardiovascular disease, chronic kidney disease, dementia and death.
Population et méthode
Cohort study in the UK Biobank. Visit-to-visit SBPV was the standard deviation of at least 3 systolic blood pressure values measured 5-10 years (Period 1) and 0-5 years (Period 2) before enrolment. Cox proportional hazards models linked absolute change in SBPV, and change patterns between the two periods, to cardiovascular disease (CVD), coronary heart disease (CHD), stroke, atrial fibrillation and flutter (AF), heart failure (HF), chronic kidney disease (CKD), dementia and overall mortality. The analysis included 36 251 participants.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Over a median follow-up of 13.9 years, an increase in SBPV from Period 1 to Period 2 was associated with higher risk of CVD, CHD, stroke, CKD and overall mortality in fully adjusted models (all P for trend < .005), a 23%-33% higher risk comparing participants above Tertile 3 with those below Tertile 1.
- 2Increases in SBPV appeared linked to higher risk of AF, HF and dementia, but these did not reach statistical significance at P < .005.
- 3Restricted cubic spline analysis found no non-linear associations (all P for non-linearity > .05).
- 4Compared with consistently low SBPV, consistently high SBPV across both periods was linked to higher risk of CVD, CHD, stroke, AF, HF, CKD and overall mortality, a 28%-46% increased risk. Results held across subgroup and sensitivity analyses.
Limites et incertitude
- 1Observational data cannot show that variability itself causes events, since unstable blood pressure may reflect underlying illness, medication changes or poor adherence.
- 2Clinic readings from earlier years vary in how and when they were taken, and the abstract does not report how many values each person had.
- 3UK Biobank volunteers tend to be healthier than the general population, so the associations may differ elsewhere.
- 4The abstract gives risk as ranges rather than a hazard ratio for each outcome, and does not give absolute risks.
Mise en perspective
Large swings in blood pressure between visits may be a marker worth mentioning to your clinician, but this study does not show that smoothing out variability would prevent events. Do not change blood pressure medication based on it. Treatment decisions belong with your clinician.
Vos données
A home blood pressure cuff lets you see variability yourself. To make readings comparable, use the same validated cuff, sit rested for a few minutes, measure at the same times of day, and note any medication changes. Judge the pattern over weeks of readings, and share the log with your clinician.
Comprendre ce type de preuve
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background and aims
Earlier studies evaluated the association between systolic blood pressure variability (SBPV) measured during a single period and risk of health outcomes. This study expanded upon existing evidence by examining the association between changes in SBPV over time and clinical outcomes in primary care settings.
Methods
Visit-to-visit SBPV was determined as standard deviation of ≥3 systolic blood pressure values measured at 5-10 (Period 1) and 0-5 (Period 2) years before enrolment in the UK Biobank. Cox proportional hazards models were used to evaluate associations of absolute changes in SBPV and SBPV change patterns between these two periods with risk of cardiovascular disease (CVD), coronary heart disease (CHD), stroke, atrial fibrillation and flutter (AF), heart failure (HF), chronic kidney disease (CKD), dementia, and overall mortality.
Results
A total of 36 251 participants were included with a median follow-up time of 13.9 years. In the fully adjusted models, an increased SBPV from Period 1 to Period 2 was significantly associated with an increased risk of CVD, CHD, stroke, CKD, and overall mortality (all P for trend < .005), reflecting a 23%-33% increased risk comparing participants with an increase in SBPV above Tertile 3 with those below Tertile 1. An increase in SBPV from Period 1 to Period 2 appeared to be associated with an increased risk of AF, HF, and dementia; however, the associations did not reach statistical significance at P < .005. The restricted cubic spline analysis did not reveal non-linear associations, as all P-values for non-linearity were >.05. Regarding SBPV change patterns, compared with the participants with consistently low SBPV, participants with a consistently high SBPV during the two periods had an increased risk of CVD, CHD, stroke, AF, HF, CKD, and overall mortality, with a risk evaluation of 28%-46%. The observed associations remained largely unchanged across subgroup and sensitivity analyses.
Conclusions
An increase in SBPV over time was associated with an elevated risk of CVD, CKD, and overall mortality. These findings provide compelling evidence to inform the importance for the management of SBPV in clinical practice.
Sources et attribution
Systolic blood pressure variability: risk of cardiovascular events, chronic kidney disease, dementia, and death.
Cheng X, Song C, Ouyang F, Ma T, He L, Fang F, Zhang G, Huang J, Bai Y.
European heart journal · 2025-07-01
DOI: 10.1093/eurheartj/ehaf256 ↗PubMed · 40249367 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

